MARKET

CORT

CORT

Corcept Therapeutics Inc
NASDAQ
87.99
+0.86
+0.99%
After Hours: 88.80 +0.81 +0.92% 19:47 12/12 EST
OPEN
87.23
PREV CLOSE
87.13
HIGH
88.73
LOW
86.13
VOLUME
1.03M
TURNOVER
--
52 WEEK HIGH
117.33
52 WEEK LOW
49.00
MARKET CAP
9.26B
P/E (TTM)
99.33
1D
5D
1M
3M
1Y
5Y
1D
Theravance Bio (TBPH) Down 3.7% Since Last Earnings Report: Can It Rebound?
NASDAQ · 4d ago
3 ‘Strong Buy’ Stocks to Buy Today, 12/9/2025, According to Top Analysts
TipRanks · 5d ago
Canaccord Genuity Sticks to Their Buy Rating for Corcept Therapeutics (CORT)
TipRanks · 5d ago
Weekly Report: what happened at CORT last week (1201-1205)?
Weekly Report · 6d ago
Notable Thursday Option Activity: WBD, CALM, CORT
NASDAQ · 12/04 20:18
Corcept Therapeutics Officer Sean Maduck Reports Disposal of Common Shares
Reuters · 12/04 01:54
Corcept Therapeutics CEO Joseph K. Belanoff Reports Disposal of Common Shares
Reuters · 12/04 01:15
3 ‘Strong Buy’ Stocks Backed by Technical Analysis
TipRanks · 12/03 13:27
More
About CORT
Corcept Therapeutics Incorporated is a commercial-stage company. The Company is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.

Webull offers Corcept Therapeutics Inc stock information, including NASDAQ: CORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CORT stock methods without spending real money on the virtual paper trading platform.